Supreme Court limits liability for shipping parts of patented inventions abroad

by Thompson Coburn LLP
Contact

Thompson Coburn LLP

Generally, to infringe a U.S. patent, the infringing activity — the unauthorized making, using, offering to sell, selling, or importation — occurs within the United States. However, there are exceptions to this rule. Under 35 U.S.C. § 271(f)(1) and (2), one can infringe a U.S. patent based on activity occurring out of the U.S. in two instances: (1) if “all or a substantial portion of the components of a patented invention” are supplied from the U.S., or (2) if “any component of a patented invention that is especially made or especially adapted for use in the invention and not a staple article” is supplied from the U.S.

The recent case of Life Techs. Corp. v. Promega Corp. Slip. No. 14-1538 (U.S. Feb. 22, 2017) from the U.S. Supreme Court, may have limited one of those exceptions. In interpreting the Patent Act of 1952 the Supreme Court clarified that one cannot infringe a U.S. patent under 35 U.S.C. §271(f)(1) by exporting a single component of a patented invention. They held that a single component could not comprise “all or a substantial portion of the components of a patented invention.” Liability for exporting a single component of a patented invention could only be found under 35 U.S.C. § 271(f)(2), and only then, if that component is “especially made or especially adapted for use in the invention.”

The Supreme Court’s analysis

In this case, Promega was the exclusive licensee of a patent covering a genetic testing kit including a variety of components, the component at issue being Taq polymerase. Promega sublicensed the patent to Life Technologies but later sued Life Technologies for selling kits outside the scope of their license. Life Technologies did not manufacture or sell the complete kits within the U.S., but they did manufacture the Taq polymerase component in the U.S. and ship it to the United Kingdom where the entire kit was assembled. Promega therefore based their theory of infringement on 35 U.S.C. § 271(f)(1) alleging that the export of Taq polymerase met the requirements of liability for exporting “all or a substantial portion of the components of a patented invention.”

At the Supreme Court, Life Technologies argued that a single component, the Taq polymerase, cannot qualify as “all or a substantial portion of the components of a patent invention” in the meaning of the statute. Promega’s position, with which the Federal Circuit had agreed, was that a single component can be substantial, qualitatively, if important or essential under the dictionary meaning of the term substantial.

The Supreme Court analyzed the statute at issue and did agree that the term substantial could have a qualitative or quantitative meaning based on the ordinary meaning of the word. However, the Court looked at the context of the term “substantial” within the statute and found that, as used, it could only have a quantitative meaning. The Court looked to the phrase in which the term appears “all or a substantial portion of the components” and noted that “all” and “portion” are quantitative terms. The court further noted that the term “substantial” modified “the components” rather than the “patented invention” which further suggested a quantitative interpretation.

Having resolved the ambiguity in the term “substantial,” the Court refused to adopt the flexible case-by-case analysis proposed by Promega. Rather, the Court determined that with the ambiguity of the term “substantial” resolved, more ambiguity should not be introduced by a case-by-case analysis approach as to the importance or essential nature of a component.

Importantly, the Court held that, as a matter of law, exporting a single component cannot qualify as a “substantial portion” of a patented invention, and therefore exporting a single component cannot trigger liability under 35 U.S.C. § 271(f)(1). In reaching this holding, the Court looked to the language of the statute that referenced “components” in the plural and concluded that “specifying a substantial portion of ‘components,’ plural indicates that multiple components constitute the substantial portion.”

The Court also noted that 35 U.S.C. § 271(f)(2) applies in the case where a single “especially made or especially adapted” component was exported, and therefore an interpretation of § 271(f)(1) that required more than one component be exported allowed the two statutes to work in tandem. In the case of multiple components being exported, liability was controlled by § 271(f)(1) and required all or a substantial portion of the components to be exported. In the case of a single exported component, however, liability was controlled by § 271(f)(2) and required that the exported component be especially made or adapted for use in the invention.

The opinion, and the concurring opinion of Justice Alito, left open the number of components beyond one which would qualify as a substantial portion of the invention’s components.

What’s next?

Going forward, lower courts will be tasked with determining how many components count as a substantial portion of the patented invention, and the courts will have to make this determination without guidance from the Supreme Court.

This case illustrates the importance of having an intellectual property strategy that is driven by business considerations. For example, Promega would likely be better situated if it had sued in the United Kingdom using a domestic patent given the territorial nature of patent law. Gaining patent protection in foreign countries that may be manufacturing sites and/or important sales markets allows infringement suits in multiple jurisdictions rather than relying on the limited scope of 35 U.S.C. § 271(f)(1)-(2). Furthermore, this case illustrates the importance of careful license drafting and consideration of the potential business outcomes of entering into a license agreement with another party. Licensing Life Technologies to manufacture the test kits only in the U.S. may have resulted in different results.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Thompson Coburn LLP | Attorney Advertising

Written by:

Thompson Coburn LLP
Contact
more
less

Thompson Coburn LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!